The review pursuant to Article 5.1.1.1 of the International Standard for Results Management  of an Adverse Analytical Finding, reported shortly after the TUE  expiry , withdrawal or  reversal,  shall include consideration of whether such finding is consistent with Use of the Prohibited Substance  or Prohibited Method prior to that date, in which event no anti -doping rule violation shall be asserted.